Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Abeena Brewster"'
Autor:
Jennifer J. Wheler, David S. Hong, Shubham Pant, Siqing Fu, Vivek Subbiah, Sarina Anne Piha-Paul, Alexej Ballhausen, Funda Meric-Bernstam, Kimberly Koenig, Apostolia Maria Tsimberidou, Veronica R. Holley, Nuhad K. Ibrahim, Helen J. Huang, Daniel D. Karp, Abeena Brewster, Filip Janku
Publikováno v:
Cancer Research. 80:P1-19
Background: Combinations of HER2 and aromatase or mTOR inhibitors demonstrated activity in the clinical setting. We hypothesized that the triple combination of HER2 targeted therapy, aromatase and mTOR inhibitor has increased anticancer activity. Met
Autor:
Sharon H. Giordano, Abeena Brewster, Gabriel N. Hortobagyi, Edgardo Rivera, Hai T. Tran, Ana M. Gonzalez-Angulo, Gregory W. Gladish, Massimo Cristofanilli, Daniel J. Booser, Julia A. Moore, James L. Murray, Stacy L. Moulder, Joe Ensor
Publikováno v:
Cancer. 118:2378-2384
BACKGROUND: Inhibition of mammalian target of rapamycin with everolimus may improve the efficacy of taxanes. Everolimus and docetaxel are both metabolized by CYP3A4, which could result in a pharmacokinetic (PK) interaction. METHODS: Fifteen patients
Autor:
Jay Reddy, Richard A. Larson, Rachel L. Atkinson, Wendy A. Woodward, Abeena Brewster, Adam R. Wolfe, Takae Brewer, Hiroko Masuda, Naoto T. Ueno, Bradley J. Atkinson, Li Li, Bisrat G. Debeb
Purpose: We previously demonstrated that cholesterol-lowering agents regulate radiation sensitivity of inflammatory breast cancer (IBC) cell lines in vitro and are associated with less radiation resistance among IBC patients who undergo postmastectom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53802b308a72ec7ef413d7cc452a24ed
https://europepmc.org/articles/PMC4801170/
https://europepmc.org/articles/PMC4801170/
Autor:
Stacy, Moulder, Gregory, Gladish, Joe, Ensor, Ana Maria, Gonzalez-Angulo, Massimo, Cristofanilli, James L, Murray, Daniel, Booser, Sharon H, Giordano, Abeena, Brewster, Julia, Moore, Edgardo, Rivera, Gabriel N, Hortobagyi, Hai T, Tran
Publikováno v:
Cancer. 118(9)
Inhibition of mammalian target of rapamycin with everolimus may improve the efficacy of taxanes. Everolimus and docetaxel are both metabolized by CYP3A4, which could result in a pharmacokinetic (PK) interaction.Fifteen patients with metastatic breast